A step closer to the confident production of blood stem cells for regenerative medicine May 16, 2025 A step closer to the confident production of blood stem cells for regenerative medicine
Researchers at the Josep Carreras Institute find inhibition of CBP/p300 may enhance sensitivity of MDS cells to azacytidine October 18, 2021 Researchers at the Josep Carreras Institute find inhibition of CBP/p300 may enhance sensitivity of MDS cells to azacytidine
Epigenetics predicts the efficacy of T-lymphocyte treatments in hematological malignancies September 29, 2021 Epigenetics predicts the efficacy of T-lymphocyte treatments in hematological malignancies
Dr. Manel Esteller, elected member of the prestigious European Academy of Sciences September 21, 2021 Dr. Manel Esteller, elected member of the prestigious European Academy of Sciences
New insights on the role of the MAX protein in lung cancer September 08, 2021 New insights on the role of the MAX protein in lung cancer
REDECAN publishes the latest data on the incidence of hematological neoplasms in Spain September 08, 2021 REDECAN publishes the latest data on the incidence of hematological neoplasms in Spain
The Josep Carreras Leukaemia Research Institute organizes a Single Cell Genomics Symposium August 03, 2021 The Josep Carreras Leukaemia Research Institute organizes a Single Cell Genomics Symposium
Discovered a key alteration in the genes involved in the development of Cornelia de Lange syndrome July 29, 2021 Discovered a key alteration in the genes involved in the development of Cornelia de Lange syndrome
Boosting the valorisation, technology and knowledge transfer of the projects at the Josep Carreras Leukemia Research Institute July 27, 2021 Boosting the valorisation, technology and knowledge transfer of the projects at the Josep Carreras Leukemia Research Institute
CADs: a new family of drugs to fight against acute myeloid leukemia July 21, 2021 CADs: a new family of drugs to fight against acute myeloid leukemia
Researchers at the Josep Carreras Institute find a weakness that could be exploited to treat SMARCA4 defective cancers July 14, 2021 Researchers at the Josep Carreras Institute find a weakness that could be exploited to treat SMARCA4 defective cancers
